Literature DB >> 27606036

Permutation Testing for Treatment-Covariate Interactions and Subgroup Identification.

Jared C Foster1, Bin Nan2, Lei Shen3, Niko Kaciroti4, Jeremy M G Taylor5.   

Abstract

We consider the problem of using permutation-based methods to test for treatment-covariate interactions from randomized clinical trial data. Testing for interactions is common in the field of personalized medicine, as subgroups with enhanced treatment effects arise when treatment-by-covariate interactions exist. Asymptotic tests can often be performed for simple models, but in many cases, more complex methods are used to identify subgroups, and non-standard test statistics proposed, and asymptotic results may be difficult to obtain. In such cases, it is natural to consider permutation-based tests, which shuffle selected parts of the data in order to remove one or more associations of interest; however, in the case of interactions, it is generally not possible to remove only the associations of interest by simple permutations of the data. We propose a number of alternative permutation-based methods, designed to remove only the associations of interest, but preserving other associations. These methods estimate the interaction term in a model, then create data that "looks like" the original data except that the interaction term has been permuted. The proposed methods are shown to outperform traditional permutation methods in a simulation study. In addition, the proposed methods are illustrated using data from a randomized clinical trial of patients with hypertension.

Entities:  

Keywords:  permutation tests; personalized medicine; subgroup analysis; treatment-covariate interactions

Year:  2015        PMID: 27606036      PMCID: PMC5010868          DOI: 10.1007/s12561-015-9125-9

Source DB:  PubMed          Journal:  Stat Biosci        ISSN: 1867-1764


  12 in total

1.  Detecting treatment-by-centre interaction in multi-centre clinical trials.

Authors:  R F Potthoff; B L Peterson; S L George
Journal:  Stat Med       Date:  2001-01-30       Impact factor: 2.373

2.  The mean does not mean as much anymore: finding sub-groups for tailored therapeutics.

Authors:  Stephen J Ruberg; Lei Chen; Yanping Wang
Journal:  Clin Trials       Date:  2010-07-28       Impact factor: 2.486

3.  Analysis of randomized comparative clinical trial data for personalized treatment selections.

Authors:  Tianxi Cai; Lu Tian; Peggy H Wong; L J Wei
Journal:  Biostatistics       Date:  2010-09-28       Impact factor: 5.899

4.  Subgroup identification from randomized clinical trial data.

Authors:  Jared C Foster; Jeremy M G Taylor; Stephen J Ruberg
Journal:  Stat Med       Date:  2011-08-04       Impact factor: 2.373

5.  Subgroup analysis and other (mis)uses of baseline data in clinical trials.

Authors:  S F Assmann; S J Pocock; L E Enos; L E Kasten
Journal:  Lancet       Date:  2000-03-25       Impact factor: 79.321

6.  Permutation and parametric bootstrap tests for gene-gene and gene-environment interactions.

Authors:  Petra Bůžková; Thomas Lumley; Kenneth Rice
Journal:  Ann Hum Genet       Date:  2011-01       Impact factor: 1.670

Review 7.  Large-scale randomized evidence: large, simple trials and overviews of trials.

Authors:  R Peto; R Collins; R Gray
Journal:  J Clin Epidemiol       Date:  1995-01       Impact factor: 6.437

8.  A robust method for estimating optimal treatment regimes.

Authors:  Baqun Zhang; Anastasios A Tsiatis; Eric B Laber; Marie Davidian
Journal:  Biometrics       Date:  2012-05-02       Impact factor: 2.571

9.  Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials.

Authors:  S Yusuf; J Wittes; J Probstfield; H A Tyroler
Journal:  JAMA       Date:  1991-07-03       Impact factor: 56.272

10.  Feasibility of treating prehypertension with an angiotensin-receptor blocker.

Authors:  Stevo Julius; Shawna D Nesbitt; Brent M Egan; Michael A Weber; Eric L Michelson; Niko Kaciroti; Henry R Black; Richard H Grimm; Franz H Messerli; Suzanne Oparil; M Anthony Schork
Journal:  N Engl J Med       Date:  2006-03-14       Impact factor: 91.245

View more
  2 in total

1.  A permutation procedure to detect heterogeneous treatment effects in randomized clinical trials while controlling the type I error rate.

Authors:  Jack M Wolf; Joseph S Koopmeiners; David M Vock
Journal:  Clin Trials       Date:  2022-05-09       Impact factor: 2.599

2.  Metabolomics identifies metabolite biomarkers associated with acute rejection after heart transplantation in rats.

Authors:  Feng Lin; Yi Ou; Chuan-Zhong Huang; Sheng-Zhe Lin; Yun-Bin Ye
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.